Ivermectin “obliterates” transmission of Covid, but it’s too cheap to be used

[Elderberry]

JoNova 12/11/2020

Some things matter. The biggest scandal of Covid — the one worth fighting for — is that there are drugs that work, which are safe and well tested, but  they suffer from the crippling problem of being too cheap for our captured public health institutions to use. Because they are old safe, mass produced and out of patent no Pharmaceutical giant will make mass profits, which dooms them to being ignored, under researched, and generally scoffed at in rude dismissive terms.

The biggest failure of our government health agencies right now is the Black Hole of Medicine — the astronomical event horizon beyond which cheap safe drugs disappear without a trace.

3,000 people are dying every day in the USA and 5,000 a day are dying in Europe, mostly from a problem which can be solved to a large extent.

Sure, the media hate HCQ because “Donald”. But it’s not just HCQ  and it’s not just Trump  — the media ignore all the cheap antivirals and all the rich nations have the same medical Black Hole.  This is the work of the Medical Swamp, captured by Big Pharma.

The Age of Antivirals is here and hardly anyone even knows it.

Watch Dr Pierre Kory’s exasperation and frustration. His team has an extraordinary 2,000 peer review publications on medicine between them. As he says: All we have focused on is repurposed drugs. All they focus on is novel and expensive drugs.

Any further deaths are needless deaths. “I cannot keep doing this”.

The NIH — their last recommendation was August. All I ask is for the NIH to review our data.

Please, just review our manuscript.The amount of evidence is immense.

(Video at link)

Full Transcript

Frontline Critical Care Alliance

More: https://joannenova.com.au/2020/12/ivermectin-obliterates-transmission-of-covid-but-its-too-cheap-to-be-used/

[Elderberry]

'This was a gift to us': Ivermectin effective for COVID-19 prophylaxis, treatment

Healio By Erin Michael 12/8/2020

Numerous studies have provided evidence supporting the use of ivermectin to prevent and treat COVID-19, according to the Frontline COVID-19 Critical Care Alliance.

Paul Marik, MD, FCCM, FCCP, founder of the alliance and a professor and chief of the division of pulmonary and critical care medicine at Eastern Virginia Medical School, said that ivermectin “is a safe drug that is exceedingly cheap.”

He added that “what is truly remarkable — this was a gift to us — ivermectin has high activity against COVID-19.”

In a press conference, researchers said that ivermectin is an FDA-approved anti-parasitic drug that has been available for approximately 40 years and previously earned researchers a Nobel Prize.

Ivermectin is a key factor in the alliance’s I-MASK+ protocol for prophylaxis and early treatment of outpatients with COVID-19. In the protocol, those at high risk for COVID-19 infection receive ivermectin at 0.2 mg/kg on day 1 and day 3, and weekly for 4 weeks; those who were exposed to COVID-19 receive the same dose at day 1 and day 3; and both groups receive daily doses of vitamin D3, vitamin C, quercetin, zinc and melatonin. For early outpatients with COVID-19, the protocol calls for one dose of ivermectin at 0.2 mg/kg at day 1 and day 3, along with the same daily vitamins and 325 mg per day of aspirin.

“All studies showed positive benefits — the majority showed a decrease in mortality, decreases in hospitalization,” Kory said.

In light of the positive data on ivermectin in COVID-19, the researchers called on national and global health authorities — including the NIH, WHO and the CDC — to examine the data.

“We are appealing to these national and global health authorities,” Marik said. “Please, review the data, and provide guidance to health care workers across the world so that they can prescribe this medication.”

More: https://www.healio.com/news/primary-care/20201208/this-was-a-gift-to-us-ivermectin-effective-for-covid19-prophylaxis-treatment#

[Elderberry]

Real World Evidence? I-MASK+ Protocol: Ivermectin Key for Prophylaxis and Early Treatment of COVID-19

Trial Site News Nov 3, 2020 | COVID-19, Critical Care, FLCCC, Ivermectin, News, Popular Posts, Real World Data, Real World Evidence

“The I-MASK+ protocol will revolutionize the treatment of COVID-19”

As noted, I-MASK+ is a new protocol for both prophylaxis and early outpatient treatment of COVID-19 patients. It is, “centered around the use of Ivermectin, the FDA approved,  well-known anti-parasite drug with the discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.” I-MASK+ and MATH+ are complementary in that the former excludes hospitalized patients while the later focuses on them. According to the FLCCC, all of their recommended medicines are, “FDA-approved, inexpensive, readily available and have been used for decades with well-established safety profiles.”

And according to Dr. Marik, “the I-MASK protocol will revolutionize the treatment of COVID-19.” FLCCC notes that recent studies have been negative for many treatments. These include remdesivir, HCQ, lopinavir, interferon, plasma, and mono-clonal antibody therapy. At present, the only thing officially “proven” to work is corticosteroids for moderate to severe illness and remdesivir. Of course remdesivir has a mixed record; the FDA and EMA approved despite the results of the Solidarity trial. The new protocol is based on the accumulation of published and unpublished trials showing that, “the drug Ivermectin, an anti-parasitic drug with increasingly well-known anti-viral and anti-inflammatory properties has demonstrated profound activity against COVID-19.”

FLCCC: Ivermectin Can Deliver Population-Wide Protection

 Per the FLCCC, the available evidence shows that Ivermectin: inhibits SARS-CoV-2 replication, prevents transmission within households, hastens recovery and stops deterioration in mild to moderate cases, hastens recovery/avoidance of ICU, and “leads to striking reductions in case-fatality rates in regions with population-wide distribution and use.” Perhaps most importantly, as little as one dose a week can, “lead to population-wide protection and reduced transmission in a manner that is easier to achieve, more effective, and less expensive than the still elusive and widely suspect vaccine.” One study FLCCC believes deserves special attention is by Dr. Juan Chamie; his study gives us an analysis of, “large amounts of real-world epidemiologic data in support of Ivermectin as an effective population-wide intervention in Peru.” By comparing and contrasting eight regions, some of which used population-wide prophylactic Ivermectin, Dr. Chamie was able to reach strong confidence in the drug. As to the new protocol’s name, as noted “I” is for Ivermectin, “MASK” simply means wear a mask, and the “+” is differing amounts of  vitamin D3, vitamin C, Quercetin, melatonin, zinc, and aspirin.

More: https://trialsitenews.com/real-world-evidence-i-mask-protocol-ivermectin-key-for-prophylaxis-and-early-treatment-of-covid-19/

[Elderberry]

Medical establishment's refusal to consider alternate COVID treatments is criminal

American Thinker by John M. Contino 12/22/2020

https://www.americanthinker.com/blog/2020/12/medical_establishments_refusal_to_consider_alternate_covid_treatments_is_criminal.html

On December 8, 2020, Senator Ron Johnson chaired a Senate hearing on early outpatient treatments for COVID-19 patients.  One of the participants was Dr. Pierre Kory, who back in May of this year argued that it was critically important to use cortical steroids to treat COVID patients, at a time when doctors were being told not to use them.

Dr. Kory spoke on behalf of a group of physicians who have dedicated the last nine months to the repurposing of drugs.  The NIH, the FDA, and the CDC have not assigned a task force to study repurposed drugs to treat the virus; apparently, these organizations have decided that this novel coronavirus is best treated and prevented through the novel and expensive use of pharmaceutically engineered drugs and vaccines.

In this video from his Senate testimony, Dr. Kory speaks passionately about the miraculous (his word) impact of the efficacy of a drug called Ivermectin that has emerged from the monitoring of data during the last three months.  In Argentina, 800 health care workers were given this drug prophylactically, and none got sick, whereas 58% of 400 health care workers not administered the drug contracted the virus.  He spoke of four randomized control trials and multiple observation trials that all confirm the preventative and curative effects of Ivermectin.